Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain

被引:33
作者
Dekel, R
Martinez-Hawthorne, SD
Guillen, RJ
Fass, R
机构
[1] So Arizona VA Hlth Care Syst, Dept Med, Gastroenterol Sect, Tucson, AZ 85723 USA
[2] Univ Arizona, Hlth Sci Ctr, Tucson, AZ USA
[3] Arizona Canc Ctr, Dept Biometry, Tucson, AZ USA
关键词
noncardiac chest pain; symptom index; 24-hour esophageal pH monitoring; PPI test; gastroesophageal reflux disease;
D O I
10.1097/00004836-200401000-00007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Symptom index (SI), which represents the percentage of perceived gastroesophageal reflux-related symptoms that correlate with esophageal acid reflux events (pH <4), has been suggested as a measure to improve diagnosis of gastroesophageal reflux (GER)-related noncardiac chest pain (NCCP). Because no study has evaluated the value of the symptom index in NCCP patients, data to support this claim have yet to be elucidated. Aim: To evaluate the value of SI in identifying gastroesophageal reflux disease (GERD)-related NCCP patients. Methods: Patients enrolled in this study were referred by a cardiologist after a comprehensive work-up excluded a cardiac cause for their chest pain. All patients underwent upper endoscopy to determine esophageal inflammation and 24-hour esophageal pH monitoring to assess esophageal acid exposure. Patients were instructed to record all chest pain episodes during the pH test. Patients with a positive SI (≥50%) underwent the proton pump inhibitors (PPI) test, which is a therapeutic trial using a short course of high dose PPI. Results: A total of 94 patients with NCCP were included in this study. Forty-seven (50%) had either a positive upper endoscopy or an abnormal pH test and were considered GERD-Positive. Forty-seven patients (50%) had both tests negative and were considered GERD-Negative. Total number of reflux episodes and percent total, supine and upright time pH less than 4, were significantly higher in the GERD-Positive group as compared with the GERD-Negative group (P < 0.0001, P < 0.0001, P = 0.0045, and P < 0.0001 respectively). Only 9 (19.1%) patients in the GERD-Positive group and 5 (10.6%) patients in the GERD-Negative group had a positive SI (p = ns). Eight (89%) out of the 9 patients who had a positive SI in the GERD-Positive group and 2 (40%) out of 5 patients in the GERD-Negative group responded to the PPI test. Conclusion: Positive SI is relatively uncommon in NCCP patients, regardless if GERD is present or absent. Hence, symptom index provides very little improvement in diagnosing GERD-related NCCP.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 16 条
[1]   Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux [J].
Achem, SR ;
Kolts, BE ;
MacMath, T ;
Richter, J ;
Mohr, D ;
Burton, L ;
Castell, DO .
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (10) :2138-2145
[2]   Prior sensitization of esophageal mucosa by acid reflux predisposes to reflux-induced chest pain [J].
Beedassy, A ;
Katz, PO ;
Gruber, A ;
Peghini, PL ;
Castell, DO .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 31 (02) :121-124
[3]   ANALYSIS OF 24-HOUR ESOPHAGEAL PRESSURE AND PH DATA IN UNSELECTED PATIENTS WITH NONCARDIAC CHEST PAIN [J].
BREUMELHOF, R ;
NADORP, JHSM ;
AKKERMANS, LMA ;
SMOUT, AJPM .
GASTROENTEROLOGY, 1990, 99 (05) :1257-1264
[4]   ESOPHAGEAL FUNCTION IN PATIENTS WITH ANGINA-TYPE CHEST PAIN AND NORMAL CORONARY ANGIOGRAMS [J].
DEMEESTER, TR ;
OSULLIVAN, GC ;
BERMUDEZ, G ;
MIDELL, AI ;
CIMOCHOWSKI, GE ;
ODROBINAK, J .
ANNALS OF SURGERY, 1982, 196 (04) :488-498
[5]   Non-cardiac chest pain: squeezing the life out of the Australian healthcare system? [J].
Eslick, GD ;
Talley, NJ .
MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 (05) :233-234
[6]  
Fang J, 2001, AM J GASTROENTEROL, V96, P958
[7]   The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain [J].
Fass, R ;
Fennerty, MB ;
Ofman, JJ ;
Gralnek, IM ;
Johnson, C ;
Camargo, E ;
Sampliner, RE .
GASTROENTEROLOGY, 1998, 115 (01) :42-49
[8]   Chest pain of esophageal origin [J].
Fass, R .
CURRENT OPINION IN GASTROENTEROLOGY, 2002, 18 (04) :464-470
[9]  
Fass R., 2001, MEDSCAPE GASTROENTER, V3, P1
[10]  
FENNERTY MB, 1995, HOSP MED, P15